FDA Approved Prepopik Bowel Prep Shows High Patient Tolerance

Prepopik, a low-volume bowel preparation for colonoscopies, received FDA approval last year and in the latest study of its use 58.4 percent of patients found the solution “very easy” to take, while 29 percent of patients found it “easy,” according to a Gastroenterology & Endoscopy News report.

Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!

The Ferring Pharmaceuticals prep, made of 10 grams of sodium picosulfate, 3.5 grams of magnesium oxide and 12 grams of citric acid, is to be administered in two five-ounce glasses and followed with clear liquids. Patients consume a total of two liters.

More Articles on Gastroenterology:
UCLA Health System Opens New Specialty Services Practice, Including Gastroenterology
Gastrointestinal Device Market Estimated at $33B by 2023
FDA Grants 510(k) Clearance for Invendo Medical Single-Use Colonoscopy System

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Next Up in GI & Endoscopy

FDA Approved Prepopik Bowel Prep Shows High Patient Tolerance

Next Up in GI & Endoscopy

Independent GI practices shrinks as reimbursements fall 38% over a decade

Endoscopy at scale: The reprocessing best practices separating high-performing teams

Missouri hospital adds noninvasive liver tumor treatment

Find the revenue hiding in your dental practice

Next Up in GI & Endoscopy

Independent GI practices shrinks as reimbursements fall 38% over a decade

Endoscopy at scale: The reprocessing best practices separating high-performing teams

Missouri hospital adds noninvasive liver tumor treatment

Join the 40,000+ ASC leaders who start their day with Becker's